Skyward Specialty Insurance Group Reports Fourth Quarter 2025 Results
HOUSTON, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Skyward Specialty Insurance Group, Inc. (Nasdaq: SKWD) (“Skyward Group” or the “Company”), today reported fourth quarter 2025 net income of $43.2 million, or $1.03 per diluted share, compared to $14.4 million, or $0.35 per diluted share, for the same 2024 period. Net income for the year ended 2025 was $170.0 million, or $4.07 per diluted share, compared to $118.8 million, or $2.87 per diluted share, for the same 2024 period.
Adjusted operating income(1) for the fourth quarter of 2025 was $48.9 million, or $1.17 per diluted share, compared to $33.2 million, or $0.80 per diluted share, for the same 2024 period. Adjusted operating income(1) for the year ended 2025 was $167.4 million, or $4.00 per diluted share, compared to $126.6 million, or $3.06 per diluted share, for the same 2024 period.
Highlights for the fourth quarter included:
- Gross written premiums of $439.5 million, an increase of 13.2% compared to 2024;
- Combined ratio of 88.5%;
- Ex-Cat combined ratio of 87.7%;
- Return on equity of 18.9% for the year ended December 31, 2025; and,
- Book value per share of $24.92, an increase of 26% compared to December 31, 2024.
| (1) See “Reconciliation of Non-GAAP Financial Measures” |
Skyward Group Chairman and CEO Andrew Robinson commented, “The fourth quarter was another excellent quarter and capped off a truly transformational year for the Company. Similar to the previous three quarters, we delivered Company bests in adjusted operating income(1), underwriting income(1) and the combined ratio of 88.5%. Our gross written premiums growth in the quarter of 13% culminated a year of 24% growth, and our return on equity and return on tangible equity of 18.9% and 20.9%(1) respectively for the full year are simply outstanding.”
“Our focus and disciplined execution of our ‘Rule Our Niche’ strategy, underscored by the strength of our intentionally built, diversified portfolio, where nearly half of our business is in non-cycle exposed lines, positions us particularly well given the evolving property and casualty market backdrop. As we look forward, together with additional capabilities and the outstanding Apollo team, we are extremely well-positioned as a Company to continue to build and maintain winning positions across the specialty insurance market and generate top quartile returns and long-term, sustainable shareholder value.”
Results of Operations
Underwriting Results
| Premiums | ||||||||||||||||||||||
| ($ in thousands) | Three months ended December 31, | Twelve months ended December 31, | ||||||||||||||||||||
| unaudited | 2025 | 2024 | % Change | 2025 | 2024 | % Change | ||||||||||||||||
| Gross written premiums | $ | 439,487 | $ | 388,355 | 13.2 | % | $ | 2,166,236 | $ | 1,743,232 | 24.3 | % | ||||||||||
| Ceded written premiums | $ | (156,906 | ) | $ | (117,328 | ) | 33.7 | % | $ | (760,004 | ) | $ | (619,654 | ) | 22.6 | % | ||||||
| Net retention | 64.3 | % | 69.8 | % | NM | (1) | 64.9 | % | 64.5 | % | NM | (1) | ||||||||||
| Net written premiums | $ | 282,581 | $ | 271,027 | 4.3 | % | $ | 1,406,232 | $ | 1,123,578 | 25.2 | % | ||||||||||
| Net earned premiums | $ | 356,800 | $ | 293,240 | 21.7 | % | $ | 1,304,505 | $ | 1,056,722 | 23.4 | % | ||||||||||
| (1) Not meaningful | ||||||||||||||||||||||
The increase in gross written premiums for the fourth quarter, compared to the same period in 2024, was primarily driven by growth in accident & health, specialty programs and surety, while the year‑over‑year increase for 2025 was driven by these divisions, as well as the agriculture and credit (re)insurance division.
| Combined Ratio | Three months ended December 31, | Twelve months ended December 31, | ||||||||||
| (unaudited) | 2025 | 2024 | 2025 | 2024 | ||||||||
| Non-cat loss and LAE | 60.9 | % | 60.5 | % | 60.3 | % | 60.6 | % | ||||
| Cat loss and LAE(1) | 0.8 | % | 2.2 | % | 1.2 | % | 1.7 | % | ||||
| Prior accident year development(2) | (2.1 | )% | 4.2 | % | (0.6 | )% | 1.1 | % | ||||
| Loss Ratio | 59.6 | % | 66.9 | % | 60.9 | % | 63.4 | % | ||||
| Net policy acquisition costs | 16.0 | % | 15.3 | % | 15.0 | % | 14.2 | % | ||||
| Other operating and general expenses | 13.0 | % | 13.9 | % | 13.9 | % | 15.3 | % | ||||
| Commission and fee income | (0.1 | )% | (0.3 | )% | (0.5 | )% | (0.6 | )% | ||||
| Expense ratio | 28.9 | % | 28.9 | % | 28.4 | % | 28.9 | % | ||||
| Combined ratio | 88.5 | % | 95.8 | % | 89.3 | % | 92.3 | % | ||||
| Ex-Cat Combined Ratio(3) | 87.7 | % | 93.6 | % | 88.1 | % | 90.6 | % | ||||
| (1) Current accident year | ||||||||||||
| (2) Prior accident year development for the fourth quarter and year-ended 2024 was due to the net impact of the LPT.. | ||||||||||||
| (3) Defined as the combined ratio excluding cat loss and LAE(1) | ||||||||||||
The loss ratios for the fourth quarter and year ended 2025 improved 7.3 points and 2.5 points, respectively, when compared to the same 2024 periods. The quarter and year ended 2025 benefited from (i) favorable prior accident year development compared to adverse development in the same 2024 periods, and (ii) less catastrophe losses when compared to the same 2024 periods.
The expense ratios for the fourth quarter and year ended 2025 were flat and improved 0.5 points, respectively, when compared to the same 2024 periods due to earnings leverage offset by higher acquisition costs due to the business mix shift.
Investment Results
| Net Investment Income | ||||||||||||||||
| $ in thousands | Three months ended December 31, | Twelve months ended December 31, | ||||||||||||||
| (unaudited) | 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Short-term investments & cash and cash equivalents | $ | 3,132 | $ | 3,998 | $ | 15,877 | $ | 17,643 | ||||||||
| Fixed income | 22,530 | 15,909 | 77,888 | 57,631 | ||||||||||||
| Equities | 59 | 771 | 1,380 | 2,745 | ||||||||||||
| Alternative & strategic investments | (2,209 | ) | 56 | (11,526 | ) | 2,581 | ||||||||||
| Net investment income | $ | 23,512 | $ | 20,734 | $ | 83,619 | $ | 80,600 | ||||||||
| Net unrealized (losses) gains on securities still held | $ | 5,122 | $ | (7,688 | ) | $ | (1,555 | ) | $ | 7,921 | ||||||
| Net realized gains | 107 | (2,725 | ) | 23,704 | (1,579 | ) | ||||||||||
| Net investment gains (losses) | $ | 5,229 | $ | (10,413 | ) | $ | 22,149 | $ | 6,342 | |||||||
Net investment income for the fourth quarter and year ended 2025 increased $2.8 million and $3.0 million, respectively when compared to the same 2024 periods, driven by increased income from our fixed income portfolio due to a higher yield and larger asset base.
The alternative & strategic investments portfolio continued to be impacted by the decline in the fair value of limited partnership investments. The decreases in income from the short-term investments & cash and cash equivalents was due to an overall decrease in yields when compared to the same 2024 periods. The decrease in income from equities was due to the sale of the equity portfolio in the third quarter of 2025.
Stockholders’ Equity
Stockholders’ equity was $1,009.6 million at December 31, 2025 which represented an increase of 5.0% when compared to stockholders' equity of $961.4 million at September 30, 2025. The increase in stockholders’ equity was primarily due to net income and an increase in the market value of our investment portfolio.
Conference Call
At 8:30 a.m. eastern time tomorrow, February 24, 2026, Company management will hold a conference call to discuss quarterly results with insurance industry analysts. Interested parties may listen to the discussion at under Events & Presentations. Additionally, investors can access the earnings call via conference call by registering via the conference link. Users will receive dial-in information and a unique PIN to join the call upon registering.
Non-GAAP Financial Measures
This release contains certain financial measures and ratios that are not required by, or presented in accordance with, generally accepted accounting principles in the United States (“GAAP”). We refer to these measures as “non-GAAP financial measures.” We use these non-GAAP financial measures when planning, monitoring, and evaluating our performance.
We consider these non-GAAP financial measures to be useful metrics for our management and investors to facilitate operating performance comparisons from period to period. While we believe that these non-GAAP financial measures are useful in evaluating our business, this information should be considered supplemental in nature and is not meant to be a substitute for revenue or net income, in each case as recognized in accordance with GAAP. In addition, other companies, including companies in our industry, may calculate such measures differently, which reduces their usefulness as comparative measures. For more information regarding these non-GAAP financial measures and a reconciliation of such measures to comparable GAAP financial measures, see the section entitled “Reconciliation of Non-GAAP Financial Measures.”
About Skyward Specialty Insurance Group, Inc.
Skyward Group is the holding company brand for its U.S. and Lloyds businesses, Skyward Specialty Insurance Group, Inc.® and Apollo, respectively, delivering a comprehensive suite of specialized insurance solutions across global specialty property and casualty markets. Focused on the specialty industry’s most niche, complex risks of today and the emerging challenges of tomorrow, Skyward Group leverages the forward-looking insight and disciplined execution of each organization to drive sustainable growth and long-term value for its shareholders, distribution partners and other stakeholders.
For more information about Skyward Group, Skyward Specialty and Apollo, please visit .
Forward-Looking Statements
Except for historical information, all other information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking statements are typically, but not always, identified through use of the words “believe,” “expect,” “enable,” “may,” “will,” “could,” “intends,” “estimate,” “anticipate,” “plan,” “predict,” “probable,” “potential,” “possible,” “should,” “continue,” and other words of similar meaning. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. The most significant of these uncertainties are described in Skyward Specialty's Form 10-K, and include (but are not limited to) legislative changes at both the state and federal level, state and federal regulatory rule making promulgations and adjudications, class action litigation involving the insurance industry and judicial decisions affecting claims, policy coverages and the general costs of doing business, the potential loss of key members of our management team or key employees and our ability to attract and retain personnel, the impact of competition on products and pricing, inflation in the costs of the products and services insurance pays for, product development, geographic spread of risk, weather and weather-related events, other types of catastrophic events, our ability to obtain reinsurance coverage at prices and on terms that allow us to transfer risk and adequately protect our company against financial loss, and losses resulting from reinsurance counterparties failing to pay us on reinsurance claims. These forward-looking statements speak only as of the date of this release and the Company does not undertake any obligation to update or revise any forward-looking information to reflect changes in assumptions, the occurrence of unanticipated events, or otherwise.
Skyward Specialty Insurance Group, Inc.
Media Contact
Haley Doughty
Skyward Specialty Insurance Group
713-935-4944
Investor Contact
Kevin Reed
Skyward Specialty Insurance Group
713-206-7860
| Consolidated Balance Sheets | |||||||
| ($ in thousands, except share and per share amounts) | |||||||
| (unaudited) | December 31, 2025 | December 31, 2024 | |||||
| Assets | |||||||
| Investments: | |||||||
| Fixed maturity securities, available-for-sale, at fair value (net of allowance for credit losses of $7,000 and $0, respectively) (amortized cost of $1,848,755 and $1,320,266, respectively) | $ | 1,856,303 | $ | 1,292,218 | |||
| Fixed maturity securities, held-to-maturity, at amortized cost (net of allowance for credit losses of $468 and $243, respectively) | 32,822 | 39,153 | |||||
| Equity securities, at fair value | 1,174 | 106,254 | |||||
| Mortgage loans, at fair value | 9,902 | 26,490 | |||||
| Equity method investments | 77,365 | 98,594 | |||||
| Other long-term investments | 58,650 | 33,182 | |||||
| Short-term investments, at fair value | 264,299 | 274,929 | |||||
| Total investments | 2,300,515 | 1,870,820 | |||||
| Cash and cash equivalents | 168,544 | 121,603 | |||||
| Restricted cash | 30,570 | 35,922 | |||||
| Premiums receivable, net | 544,217 | 321,641 | |||||
| Reinsurance recoverables, net | 1,119,880 | 857,876 | |||||
| Ceded unearned premium | 238,948 | 203,901 | |||||
| Deferred policy acquisition costs | 136,100 | 113,183 | |||||
| Deferred income taxes | 27,865 | 30,486 | |||||
| Goodwill and intangible assets, net | 88,040 | 87,348 | |||||
| Other assets | 137,173 | 86,698 | |||||
| Total assets | $ | 4,791,852 | $ | 3,729,478 | |||
| Liabilities and stockholders’ equity | |||||||
| Liabilities: | |||||||
| Reserves for losses and loss adjustment expenses | $ | 2,318,894 | $ | 1,782,383 | |||
| Unearned premiums | 774,035 | 637,185 | |||||
| Deferred ceding commission | 46,453 | 40,434 | |||||
| Reinsurance and premium payables | 279,888 | 177,070 | |||||
| Funds held for others | 128,003 | 102,665 | |||||
| Accounts payable and accrued liabilities | 115,034 | 76,206 | |||||
| Notes payable | 100,411 | 100,000 | |||||
| Subordinated debt, net of debt issuance costs | 19,569 | 19,536 | |||||
| Total liabilities | 3,782,287 | 2,935,479 | |||||
| Stockholders’ equity | |||||||
| Common stock, $0.01 par value, 500,000,000 shares authorized, 40,511,222 and 40,127,908 shares issued and outstanding, respectively | 405 | 401 | |||||
| Additional paid-in capital | 730,555 | 718,598 | |||||
| Accumulated other comprehensive income (loss) | 11,457 | (22,120 | ) | ||||
| Retained earnings | 267,148 | 97,120 | |||||
| Total stockholders’ equity | 1,009,565 | 793,999 | |||||
| Total liabilities and stockholders’ equity | $ | 4,791,852 | $ | 3,729,478 | |||
| Condensed Consolidated Statements of Operations and Comprehensive Income | ||||||||||||||||
| ($ in thousands) | Three months ended December 31, | Twelve months ended December 31, | ||||||||||||||
| (unaudited) | 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Revenues: | ||||||||||||||||
| Net earned premiums | $ | 356,800 | $ | 293,240 | $ | 1,304,505 | $ | 1,056,722 | ||||||||
| Commission and fee income | 415 | 806 | 6,855 | 6,703 | ||||||||||||
| Net investment income | 23,512 | 20,734 | 83,619 | 80,600 | ||||||||||||
| Net investment gains (losses) | 5,229 | (10,413 | ) | 22,149 | 6,342 | |||||||||||
| Other (loss) income | (371 | ) | 35 | (587 | ) | (167 | ) | |||||||||
| Total revenues | 385,585 | 304,402 | 1,416,541 | 1,150,200 | ||||||||||||
| Expenses: | ||||||||||||||||
| Losses and loss adjustment expenses | 212,671 | 196,320 | 795,022 | 669,809 | ||||||||||||
| Underwriting, acquisition and insurance expenses | 103,536 | 85,487 | 377,359 | 311,757 | ||||||||||||
| Transaction costs | 10,944 | — | 14,019 | — | ||||||||||||
| Interest expense | 2,290 | 2,091 | 7,919 | 9,496 | ||||||||||||
| Amortization expense | 472 | 908 | 1,636 | 2,007 | ||||||||||||
| Other expenses | 1,025 | 1,042 | 4,162 | 4,392 | ||||||||||||
| Total expenses | 330,938 | 285,848 | 1,200,117 | 997,461 | ||||||||||||
| Income before income taxes | 54,647 | 18,554 | 216,424 | 152,739 | ||||||||||||
| Income tax expense | 11,417 | 4,148 | 46,396 | 33,911 | ||||||||||||
| Net income | $ | 43,230 | $ | 14,406 | $ | 170,028 | $ | 118,828 | ||||||||
| Comprehensive income: | ||||||||||||||||
| Net income | $ | 43,230 | $ | 14,406 | $ | 170,028 | $ | 118,828 | ||||||||
| Other comprehensive income: | ||||||||||||||||
| Unrealized gains and losses on investments: | ||||||||||||||||
| Net change in unrealized gains (losses) on investments, net of tax | 3,092 | (14,735 | ) | 33,092 | 9,792 | |||||||||||
| Reclassification adjustment for (losses) gains on securities no longer held, net of tax | (1,174 | ) | (5,682 | ) | 485 | (8,959 | ) | |||||||||
| Total other comprehensive income (loss) | 1,918 | (20,417 | ) | 33,577 | 833 | |||||||||||
| Comprehensive income (loss) | $ | 45,148 | $ | (6,011 | ) | $ | 203,605 | $ | 119,661 | |||||||
| Share and Per Share Data | ||||||||||||||||
| ($ in thousands, except share and per share amounts) | Three months ended December 31, | Twelve months ended December 31, | ||||||||||||||
| (unaudited) | 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Weighted average basic shares | 40,494,443 | 40,107,617 | 40,407,310 | 40,056,475 | ||||||||||||
| Weighted average diluted shares | 41,902,370 | 41,622,397 | 41,808,046 | 41,377,460 | ||||||||||||
| Basic earnings per share | $ | 1.07 | $ | 0.36 | $ | 4.21 | $ | 2.97 | ||||||||
| Diluted earnings per share | $ | 1.03 | $ | 0.35 | $ | 4.07 | $ | 2.87 | ||||||||
| Basic adjusted operating earnings per share | $ | 1.21 | $ | 0.83 | $ | 4.14 | $ | 3.16 | ||||||||
| Diluted adjusted operating earnings per share | $ | 1.17 | $ | 0.80 | $ | 4.00 | $ | 3.06 | ||||||||
| Annualized ROE (1) | 17.5 | % | 7.2 | % | 18.9 | % | 16.3 | % | ||||||||
| Annualized adjusted ROE (2) | 19.8 | % | 16.7 | % | 18.6 | % | 17.4 | % | ||||||||
| Annualized ROTE (3) | 19.3 | % | 8.1 | % | 20.9 | % | 18.6 | % | ||||||||
| Annualized adjusted ROTE (4) | 21.8 | % | 18.8 | % | 20.6 | % | 19.8 | % | ||||||||
| December 31 | December 31 | |||||||||||||||
| 2025 | 2024 | |||||||||||||||
| Shares outstanding | 40,511,222 | 40,127,908 | ||||||||||||||
| Fully diluted shares outstanding | 42,292,371 | 42,059,182 | ||||||||||||||
| Book value per share | $ | 24.92 | $ | 19.79 | ||||||||||||
| Fully diluted book value per share | $ | 23.87 | $ | 18.88 | ||||||||||||
| Fully diluted tangible book value per share | $ | 21.79 | $ | 16.80 | ||||||||||||
| (1) Annualized ROE is net income expressed on an annualized basis as a percentage of average beginning and ending stockholders' equity during the period | ||||||||||||||||
| (2) Annualized adjusted ROE is adjusted operating income expressed on an annualized basis as a percentage of average beginning and ending stockholders' equity during the period | ||||||||||||||||
| (3) Annualized ROTE is net income expressed on an annualized basis as a percentage of average beginning and ending tangible stockholders' equity during the period | ||||||||||||||||
| (4) Annualized adjusted ROTE is adjusted operating income expressed on an annualized basis as a percentage of average beginning and ending tangible stockholders' equity during the period | ||||||||||||||||
Adjusted operating income – We define adjusted operating income as net income excluding the impact of certain items that may not be indicative of underlying business trends, operating results, or future outlook, net of tax impact. We use adjusted operating income as an internal performance measure in the management of our operations because we believe it gives our management and other users of our financial information useful insight into our results of operations and our underlying business performance. Adjusted operating income should not be viewed as a substitute for net income calculated in accordance with GAAP, and other companies may define adjusted operating income differently.
| ($ in thousands) | Three months ended December 31, | Twelve months ended December 31, | |||||||||||||||||||||||||||||
| (unaudited) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||||||||||
| Pre-tax | After-tax | Pre-tax | After-tax | Pre-tax | After-tax | Pre-tax | After-tax | ||||||||||||||||||||||||
| Income as reported | $ | 54,647 | $ | 43,230 | $ | 18,554 | $ | 14,406 | $ | 216,424 | $ | 170,028 | $ | 152,739 | $ | 118,828 | |||||||||||||||
| Less (add): | |||||||||||||||||||||||||||||||
| Net investment gains (losses) | 5,229 | 4,137 | (10,413 | ) | (8,226 | ) | 22,149 | 17,401 | 6,342 | 5,010 | |||||||||||||||||||||
| Net impact of loss portfolio transfer | — | — | (12,398 | ) | (9,794 | ) | — | — | (11,598 | ) | (9,162 | ) | |||||||||||||||||||
| Transaction costs | (10,944 | ) | (8,658 | ) | — | — | (14,019 | ) | (11,014 | ) | — | — | |||||||||||||||||||
| Other (loss) income | (371 | ) | (293 | ) | 35 | 28 | (587 | ) | (461 | ) | (167 | ) | (132 | ) | |||||||||||||||||
| Other expenses | (1,025 | ) | (811 | ) | (1,042 | ) | (823 | ) | (4,162 | ) | (3,270 | ) | (4,392 | ) | (3,470 | ) | |||||||||||||||
| Adjusted operating income | $ | 61,758 | $ | 48,855 | $ | 42,372 | $ | 33,221 | $ | 213,043 | $ | 167,372 | $ | 162,554 | $ | 126,582 | |||||||||||||||
Underwriting income – We define underwriting income as net income before income taxes excluding net investment income, net realized and unrealized gains and losses on investments, impairment charges, interest expense, amortization expense, transaction costs and other income and expenses. Underwriting income represents the pre-tax profitability of our underwriting operations and allows us to evaluate our underwriting performance without regard to investment income. We use this metric as we believe it gives our management and other users of our financial information useful insight into our underlying business performance. Underwriting income should not be viewed as a substitute for pre-tax income calculated in accordance with GAAP, and other companies may define underwriting income differently.
| ($ in thousands) | Three months ended December 31, | Twelve months ended December 31, | ||||||||||||||
| (unaudited) | 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Income before income taxes | $ | 54,647 | $ | 18,554 | $ | 216,424 | $ | 152,739 | ||||||||
| Add: | ||||||||||||||||
| Transaction costs | 10,944 | — | 14,019 | — | ||||||||||||
| Interest expense | 2,290 | 2,091 | 7,919 | 9,496 | ||||||||||||
| Amortization expense | 472 | 908 | 1,636 | 2,007 | ||||||||||||
| Other expenses | 1,025 | 1,042 | 4,162 | 4,392 | ||||||||||||
| Less (add): | ||||||||||||||||
| Net investment income | 23,512 | 20,734 | 83,619 | 80,600 | ||||||||||||
| Net investment gains (losses) | 5,229 | (10,413 | ) | 22,149 | 6,342 | |||||||||||
| Other (loss) gain | (371 | ) | 35 | (587 | ) | (167 | ) | |||||||||
| Underwriting income | $ | 41,008 | $ | 12,239 | $ | 138,979 | $ | 81,859 | ||||||||
Tangible Stockholders’ Equity – We define tangible stockholders’ equity as stockholders’ equity less goodwill and intangible assets. Our definition of tangible stockholders’ equity may not be comparable to that of other companies and should not be viewed as a substitute for stockholders’ equity calculated in accordance with GAAP. We use tangible stockholders’ equity internally to evaluate the strength of our balance sheet and to compare returns relative to this measure.
| ($ in thousands) | December 31, | |||||
| (unaudited) | 2025 | 2024 | ||||
| Stockholders’ equity | $ | 1,009,565 | $ | 793,999 | ||
| Less: Goodwill and intangible assets | 88,040 | 87,348 | ||||
| Tangible stockholders’ equity | $ | 921,525 | $ | 706,651 | ||
| Three months ended December 31, | Twelve months ended December 31, | |||||||||||||||||
| ($ in thousands) | 2025 | 2024 | % Change | 2025 | 2024 | % Change | ||||||||||||
| Accident & Health | $ | 67,297 | $ | 44,594 | 50.9 | % | $ | 254,102 | $ | 173,073 | 46.8 | % | ||||||
| Agriculture and Credit (Re)insurance | 18,687 | 21,113 | (11.5 | )% | 346,212 | 118,070 | 193.2 | % | ||||||||||
| Captives | 62,376 | 57,765 | 8.0 | % | 275,694 | 241,902 | 14.0 | % | ||||||||||
| Construction & Energy Solutions | 58,558 | 73,837 | (20.7 | )% | 274,318 | 296,582 | (7.5 | )% | ||||||||||
| Global Property | 19,801 | 18,713 | 5.8 | % | 178,128 | 201,796 | (11.7 | )% | ||||||||||
| Professional Lines | 34,320 | 39,130 | (12.3 | )% | 149,231 | 159,785 | (6.6 | )% | ||||||||||
| Specialty Programs | 91,304 | 52,151 | 75.1 | % | 322,705 | 218,407 | 47.8 | % | ||||||||||
| Surety | 45,876 | 37,889 | 21.1 | % | 168,148 | 143,965 | 16.8 | % | ||||||||||
| Transactional E&S | 41,362 | 43,163 | (4.2 | )% | 197,779 | 189,669 | 4.3 | % | ||||||||||
| Total gross written premiums(1) | $ | 439,581 | $ | 388,355 | 13.2 | % | $ | 2,166,317 | $ | 1,743,249 | 24.3 | % | ||||||
| (1) Excludes exited business | ||||||||||||||||||
This press release was published by a CLEAR® Verified individual.
